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ABSTRACT  Experimental  evidence  is presented  that supports a cell  cycle model  showing that 
there  are  five  distinct  biological  processes  involved  in  proadipocyte  differentiation.  These 
include:  (a) growth arrest at a distinct state in the G1 phase of the cell cycle; (b)  nonterminal 
differentiation;  (c)  terminal  differentiation;  (d)  loss of the differentiated  phenotype; and  (e) 
reinitiation  of  cell  proliferation.  Each of  these  events  is  shown  to  be  regulated  by  specific 
human  plasma  components  or other  physiological  factors.  At two  states designated  GD and 
GD', coupling  of growth  arrest and  differentiation  is shown  to occur.  We  propose  that these 
mechanisms for the coupling of growth arrest and differentiation are physiologically significant 
and mimic the regulatory processes  that control  stem cell  proliferation  in vivo. 
Cell proliferation in vivo and in vitro can be regulated by the 
coupling of growth arrest and cell differentiation (7, 8, l 1, 12, 
16). The mechanisms that control the coupling process have 
been studied using BALB/c 3T3 T proadipocytes which differ- 
entiate into fat ceils in culture (5,  10, 16). We established that, 
before expression of the adipocyte phenotype, growth arrest 
must occur at a state in the G~ phase of the cell cycle, designated 
GD, and that Go is distinct from other G~ growth arrest states, 
including those induced by density-dependent growth inhibi- 
tion, growth factor deprivation, and nutrient deprivation (16). 
Only Go-arrested cells: (a) can express the differentiated phe- 
notype  in  the  absence  of DNA  synthesis  (16);  (b)  can  be 
stimulated  to  proliferate  when  exposed  to  methyl  isobutyl 
xanthine  (16);  and (c) are sensitive to a cytotoxic effect of 8- 
bromo cyclic AMP (6). The GD arrest state is also distinct from 
other G1 states on the basis of topographical analysis (19).  In 
previous studies,  however, it has been difficult to distinguish 
other possible stages in the differentiation process because of 
technical limitations. 
In  the  preceding  paper  (10)  we  described  a  new  culture 
system that induces proadipocyte GD arrest and differentiation. 
It was established that culture of low density proadipocytes in 
heparinized  medium  containing  human  plasma  induces  Go 
arrest  and  differentiation  in  a  rapid,  highly  efficient,  and 
parasynchronous manner. With this method it is now possible 
to  perform  more  detailed  studies  on  the  mechanisms  that 
regulate the coupling process. Data are presented in this paper 
which provide the basis for a new model that shows that five 
distinct biological processes are involved in proadipocyte dif- 
ferentiation and that coupling of growth arrest and differentia- 
tion occurs at two states,  designated GD and Go'. 
MATERIALS  AND  METHODS 
General 
The BALB/3T3 T proadipocyte cell line was used in this study. To induce Go 
arrest and differentiation, 3T3 T  cells were cultured in heparinized Dulbecco's 
modified Eagle's medium (DME) containing either 25% human plasma or human 
plasma fractions as described (10). The methods used to measure [3H]thymidine 
incorporation by autoradiography and to perform flow microlluorimetric  analysis 
of the DNA content to characterize cell cycle distribution have been previously 
described (10,  16), as have the assays used to determine morphological differen- 
tiation (10,  16). The activity of glycerol-3-phosphate dehydrogenase (9) was also 
used as an assay for adipocyte differentiation, because it has recently been shown 
that, under selected culture conditions, cells can undergo enzymatic differentia- 
tion in the absence of morphological differentiation (17). The density of undif- 
ferentiated and differentiated ceils was quantitated by microscopic analysis using 
calibrated eyepieces; cell counts assayed between  300 and  500 ceils for each 
specimen. 
Preparation  of Human  Plasma Fractions 
Citrate anticoagulated platelet-poor human plasma was prepared from human 
blood obtained by venipuncture as described (10).  It was then fractionated by 
either of the two methods. The first method of human plasma fractionation was 
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adsorbed  repeatedly with  barium  chloride.  This  produced  barium  absorbed 
plasma (BaP) and plasma components bound to the barium citrate precipitate. 
Sequential elution of the  barium  adsorbed  plasma components with sodium 
citrate and ethylenediamine tetraacetic acid produced two fractions designated 
CEP and EDTAP, respectively. 
A  second method was developed to produce another fraction with different 
biological activity. With this method the pH at which the barium adsorption was 
performed was changed from pH 7.8 to 8.7. More specifically, citrate anticoagu- 
lated human plasma was adjusted to pH 8.7 with 1 N  NaOH; barium chloride 
was then added slowly to a final concentration of 0. l M. The pH was readjusted 
to  8.7  and  continuaUy  stirred  at  4°C  for  30  min.  The  suspension was  then 
centrifuged at 3600 g  for 25  min at 4°C.  The  sediment was finally partially 
solubilized by addition of 0.9%  NaCI4).02 M  sodium citrate. This suspension 
was stirred for 45 rain at 4°C and then sedimented as above. The supernatant, 
which was extensively dialyzed against 6.5 mM sodium citrate-citric acid buffer 
(pH 7.4),  was designated CEPH.  Other methods of procedure are described in 
detail in the preceding paper (10). 
RESULTS 
The culture of rapidly growing low density proadipocytes in 
heparinized medium containing human plasma induces growth 
arrest and differentiation.  The studies described in this paper 
were designed to establish: (a) if reversible growth arrest at a 
distinct state in the G1 phase of the cell cycle precedes differ- 
entiation; (b) if the differentiation process involves nonterminal 
and  terminal phases;  (c)  if nonterminally differentiated  cells 
can be induced to dedifferentiate;  and (d) if Go-arrested and 
dedifferentiated cells can be induced to reinitiate cell prolifer- 
ation. 
Growth Arrest at the G D State 
The culture of proadipocytes in heparinized  medium con- 
taining human plasma induces growth arrest at a distinct state 
in  the  GI  phase  of the  cell cycle,  Go,  and  their  subsequent 
differentiation (10,  16). In order to further establish that Go is 
a  specific  phase  in  the  coupling  process,  we  attempted  to 
identify experimental conditions that would induce and main- 
tain cells in the Go arrest state in the absence of differentiation 
and in the absence of DNA synthesis. Three criteria were used 
to establish that cells were at the GD state. First, cells had to 
have a 2 N  DNA content, which is characteristic of cells growth 
arrested in the G1 phase of the cell cycle. Second, cells had to 
show  mitogenic  responsiveness  to  methyl  isobutyl  xanthine 
(MIX) (16). Third, the cells had to be capable of expressing the 
adipocyte phenotype  without DNA  synthesis (16).  The  latter 
two biological characteristics distinguish Go arrested cells from 
cells arrested at other states in the G1 phase  of the cell cycle 
(16). 
Since  adsorption  of  citrated  human  plasma  with  barium 
chloride  removes  its  differentiation-promoting  activity,  we 
tested to determine if the culture of proadipocytes in heparin- 
ized  medium  containing  barium  adsorbed  plasma  (BaP)  in- 
duces  cells  to  growth  arrest  at  Go  without  subsequently  ex- 
pressing  a  differentiated  phenotype.  The  data  presented  in 
Tables I-III support this possibility. Table I shows that culture 
of proadipocytes  in  heparinized medium containing  BaP  in- 
duces the growth arrest in >90% of the cells in the G1 phase of 
the  cell cycle.  Growth  arrest  under  these  culture  conditions 
occurs within 3 d, and the kinetics of growth arrest assayed by 
decreased incorporation of [3H]thymidine into DNA were com- 
parable  to those observed when proadipocytes were cultured 
in heparmized DME containing complete human plasma. We 
also  observed  that  cells  could  be  maintained  at  Go  in  this 
medium for intervals as long as 2  wk without loss of viability 
and without loss of the GD associated characteristics described 
TABLE  I 
Induction of Growth Arrest of Proadipocytes in the G I Phase 
of the Cell Cycle by Culture in Heparinized Medium 
Containing Barium Adsorbed Human Plasma 
Cell cycle distribution 
G~  S  G2/M 
% 
Rapidly growing cells  54  24  22 
Cells growth-arrested  in  BaP  93  3  4 
The  distribution  of cell  populations  in  various phases of the cell  cycle was 
determined  by flow  microfluorography  using  a FACS IV apparatus  (see Ma- 
terials and Methods). BaP designates heparinized DME containing 25% barium 
adsorbed  human  plasma.  Cells  were assayed during exponential growth  or 
after culture in  BaP for either 4 or 8 d. Comparable results were obtained for 
both specimens  cultured in  heparinized medium containing  BaP 
TABLE  II 
Mitogenic Responsiveness to Methyl Isobutyl Xanthine of 
Proadipocytes Growth-Arrested in  Heparinized Medium 
Containing Barium Adsorbed Human Plasma 
Growth  arrest  medium 
supplement  Labeled  nuclei 
% 
0.5%  FCS  5 
25% BaP  46 
25%  HP  42 
Cells were growth-arrested by culture in DME-0.5% fetal calf serum  (FCS)  for 
4-6 d  or by culture  in  heparinized  DME containing either barium  adsorbed 
human plasma  (BaP)  or complete  human  plasma  (HP) for 4 to 8 d. To the 
culture medium was then added methyl isobutyl xanthine, final concentration 
5 x  10  -4 M, and  [aH]thymidine. Cells were incubated in this medium for 48 
h and were then fixed and processed  for autoradiographic analysis  to deter- 
mine  the extent of DNA  synthesis.  The  data represent  the percent  labeled 
nuclei  in  MiX-treated  cells  minus  the  percent  labeled  nuclei  in  untreated 
cells. 
TABLE  III 
Induction of Differentiation of Cells  Go-Arrested in 
Heparinized  Medium  Containing  Barium Adsorbed  Human 
Plasma 
Adipocyte  Labeled 
Treatment  differentiation  nuclei 
%  Fat cells/cm 2  % 
BaP alone  5  23  1 
BaP x  4 d, then CEP  52  280  6 
BaP x  8 d, then CEP  65  325  3 
Cells  were cultured in heparinized medium containing  BaP for 4 or 8 d.  CEP 
was then added together with  [aH]thymidine and the cells were cultured for 
12  additional  days;  at  4-d  intervals  cultures  were  fed  fresh  heparinized 
medium containing  BaP or  BaP and  CEP in addition to [aH]thymidine.  The 
cells  were then fixed in formaldehyde-glutaraldehyde  and  prepared  for au- 
toradiography.  The  extent  of  adipocyte  differentiation  was  assayed both 
before and after autoradiography with  comparable  results.  The  percent  la- 
beled nuclei indicated includes all cells  that incorporate [aH]thymidine from 
the time that CEP was added until termination of the experiment. 
in Tables II and III. These characteristics included mitogenic 
responsiveness to MIX and the capacity to differentiate without 
DNA  synthesis. The data in Table  II show that cells growth- 
arrested  by  culture  in  heparinized  medium  containing  BaP 
respond to the mitogenic effect of MIX in a manner similar to 
cells Go-arrested by culture in heparinized medium containing 
complete human  plasma.  This  is in contrast to ceils growth- 
arrested in G1 following serum deprivation; such cells are not 
sensitive to MIX-induced mitogenesis. 
The  data  in  Table  III provide  additional  support  for  the 
conclusion that proadipocytes can be arrested and maintained 
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heparinized medium containing BaP. The data show that after 
addition  of CEP to  cells  G1  growth-arrested  in  beparinized 
medium  containing  BaP,  differentiation  proceeds  without 
DNA synthesis. We interpret these data to support the conclu- 
sion that Go arrest and differentiation are separable events. 
Nonterminal and Terminal Differentiation 
Studies were next performed to determine if the differentia- 
tion of proadipocytes is a  terminal or a nonterminal process. 
We first assayed whether adipocyte differentiation in heparin- 
ized DME containing human plasma is tightly coupled to the 
loss of proliferative capacity. The data in Fig. 1 show that there 
is approximately a 3-d lag between expression of the adipocyte 
phenotype  and  loss  of proliferative  potential,  i.e.,  terminal 
differentiation.  This suggests that a stage of nonterminal dif- 
ferentiation must exist.  For example, Fig. 1 shows that on the 
sixth day, when approximately 50% of the cells  are differen- 
tiated, 95% can be induced to incorporate [aH]thymidine into 
DNA. However, after the  12th  day, minimal proliferation of 
differentiated cells can be detected. 
To substantiate  the possibility that there is  a  nonterminal 
phase  of adipocyte differentiation,  we attempted  to identify 
experimental conditions that would limit the terminal phase of 
differentiation  and  thereby  enrich  cultures  in  nonterminally 
differentiated cells.  We found that the culture of low density 
cells in beparinized DME containing a plasma fraction desig- 
nated CEPH achieved this result.  Table IV presents data on 
the relative ability of human plasma, BaP, and CEPH to induce 
adipocyte differentiation.  It shows that  heparinized  medium 
containing only CEPH can induce differentiation comparable 
to  that  observed  in  heparinized  medium  containing  whole 
plasma.  The culture of proadipocytes in medium containing 
CEPH was also found to induce GL growth arrest. Flow micro- 
fluorimetric  analysis of such cells showed the following cell 
cycle distribution: G1, 87%; S, 3%; Gs/M,  10%. 
The data in Table V establish that heparinized DME con- 
taining CEPH selectively induces nonterminal adipocyte dif- 
ferentiation  at  a  state  we  have  designated  GD'.  If ceils  are 
cultured  in  heparinized  DME  containing  CEPH  for 8  d  or 
longer, they differentiate but can be induced to lose the differ- 
entiated  phenotype  when  exposed  to  retinoic  acid  or other 
TABLE IV 
Differentiation of Proadipocytes  Cultured in Heparinized 
Medium Containing Different Human Plasma Fractions 
Additives to  Adipocyte 
heparinized DME  differentiation 
% 
H P  65-95 
CEPH  50-75 
BaP  5-10 
CEP  0-10 
BaP and CEP  50-70 
Serum  0 
Low density proadipocytes were cultured in heparinized DME containing the 
designated plasma fractions at concentrations calculated to be comparable to 
25% whole plasma or in DME containing 10% FC5. Cells were fed these media 
at 4-d  intervals for 12  d  and  were assayed  to  the extent  of morphological 
adipocyte differentiation on the 15th  day, The results are given as the range 
in the percent adipocyte differentiation observed in three or more experiments 
with the indicated plasma fractions. HP designates whole human plasma; the 
description of the other plasma fractions are detailed in Materials and Meth- 
ods. 
TABLE  V 
Nonterminal Differentiation Resulting  from Culture of 
Proadipocytes  in Heparinized Medium Containing a Plasma 
Fraction Designated  CEPH 
Loss of the 
differen- 
Heparinized  Differentiated  tiated phe- 
DME additives  Other additives  cells  notype 
Adipocytes/cm 2  % 
H P  2,350 
HP  Retinoic  2,525  0 
acid 
CEPH  1,545 
CEPH  Retinoic  513  67 
acid 
Low density cells were cultured  in  heparinized  DMI= containing either 25% 
human  plasma  (HP)  or CEPH for 12 d  with  refeeding at 4-d  intervals. They 
showed comparable differentiation kinetics. Retinoic acid (10-20 #g/ml)  was 
then added on the 12th day to one-half of the flasks and the quantity of fat 
cells present was determined on the 15th  day. During this interval a gradual 
loss of the adipocyte phenotype was morphologically evident in CEPH-treated 
cells.  Since  retinoic  acid  is  cytotoxic  to  some  cells,  the  data  have  been 
corrected for maximum  potential  cytotoxicity. Comparable results were ob- 
tained in two separate experiments, 
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FIGURE  1  Nonterminal and terminal phases of adipocyte differen- 
tiation.  Low  density  proadipocytes were  cultured  in  heparinized 
DME containing human plasma. Periodically, the cells were assayed 
for their extent of differentiation and for their ability to proliferate. 
For the latter assays, cells were refed DME containing 30% FCS and 
[3H]thymidine and the percent of the cells that synthesized DNA in 
the subsequent 48 h was determined autoradiographically. The data 
show that adipocyte differentiation occurs before the loss of prolif- 
erative potential. 
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select drugs; they can also be induced to synthesize DNA if 
subsequently fed 30% fetal calf serum (FCS) (Table V and Fig. 
2A).  By  contrast,  retinoic  acid  does  not  induce  significant 
numbers  of cells  cultured  in  heparinized  DME  containing 
complete human plasma for 10-12 d to lose the differentiated 
phenotype. Addition of mitogens, such as 30% serum, also does 
not induce the latter cells to incorporate [~H]thymidine (Fig. 
1). 
These observations suggest that nonterminal  and terminal 
adipocyte differentiation  are  distinct  phases  in  the coupling 
process and that CEPH lacks the plasma components required 
for terminal  differentiation.  The data presented  in Table VI 
support this conclusion. They show that nonterminally differ- 
entiated  cells  cultured  in  heparinized  medium  containing 
CEPH can be converted to a terminally differentiated state by 
addition of complete human plasma,  or the plasma fractions 
designated BaP or EDTAP, but not by CEP. Loss of the Differentiated Phenotype 
The data reported in Table V and Fig. 2 show that nonter- 
minally differentiated  cells can be induced to lose the differ- 
entiated phenotype and reinitiate cell proliferation. These two 
events  are  separable  processes  because  the  data  show  that, 
although 67% of nonterminally differentiated cells cultured in 
heparinized medium containing CEPH can be induced to lose 
the differentiated phenotype during a  3-d interval in retinoic 
acid,  <1% of the  ceils  incorporate  [3Hlthymidine  into  DNA 
during  this  interval.  Reinitiation  of proliferation  of cells  in- 
duced  to  dedifferentiate  by  retinoic  acid  requires  treatment 
with  serum  or  other  mitogenic  agents  (Fig.  2).  Loss of the 
differentiated phenotype and reinitiation  of proliferation are, 
therefore,  separate phases in the coupling process. Under se- 
lected  experimental  conditions  it  is  also  possible  to  induce 
nonterminally differentiated  adipocytes to proliferate without 
loss of the differentiated phenotype (data not shown). 
Reinitiation  of  Cell  Proliferation 
Cells which have GD-arrested but which have not expressed 
the adipocyte phenotype can also be induced to reinitiate DNA 
synthesis and traverse the cell cycle by addition of a variety of 
mitogens  directly  to  the  differentiation-promoting  medium. 
The data in Table VII list  these mitogens. They include epi- 
dermal growth factor, phorbol myristate acetate,  methyl iso- 
butyl xanthine,  30% fetal calf serum,  and a  cyst fluid,  desig- 
nated  TuGF,  which  was  derived  from  tumors  induced  by 
implantation  of BALB/c 3T3 cells on plastic plates into syn- 
geneic mice (4,  15). 
TAatE  Vl 
Requirements for Specific Plasma Factors to Induce Terminal 
Adipocyte Differentiation 
Loss of the adipocyte phenotype 
Condition  A  Condition  B 
Heparinized 
DME additives  Control  Treated  %  % 
A  dipocytes/cm  2 
C E  P  H  1,875  600  68  70 
CEPH  and CEP  68 
CEPH  and  BaP  2,375  1,500  37  0 
CEPH  and  HP  2,200  1,850  16  0 
CEPH and  EDTAP  2,775  2,125  23 
Condition A: Low density cells were cultured in heparinized  DMEcontaining 
25%  CEPH  for 12 d  with prior feedings  at 4-d  intervals.  On the 12th day an 
aliquot of complete human  plasma  (HP),  barium adsorbed  human  plasma 
(BaP), or the EDTA eluate of barium  adsorbed  plasma components (EDTAP) 
was  added.  The  concentration  of  these  additives  was  equivalent  to  that 
calculated  to be present  in  25%  HP. The  ability of the adipocytes,  cultured 
under various conditions, to lose the differentiated phenotypes  was tested 3- 
d  later by  removal  of the differentiation-promoting medium  and culture of 
the cells  in  DME containing 30% fetal calf serum.  Loss of the differentiated 
phenotype is expressed as the percent  decrease in the density of fat cells. It 
was determined  by  analysis of the number of fat cells/cm  2 present  before 
(control)  and  3-d  after addition  of DME-FCS (treated).  Cell  density analysis 
showed  that  loss of the differentiated  phenotypes  was not associated with 
any cytotoxicity. Condition  B: Comparable results were obtained when reti- 
noic acid  (10-20 p.g/ml)  was used to induce loss of the adipocyte phenotype. 
In  these  studies  low  density  cells  were cultured  in  heparinized  medium 
containing  CEPH  for 8 d with feeding at 4-d  intervals.  On the eighth day the 
cultures  were refed medium containing either  HP,  BaPor CEP. On the 12th 
day  retinoic acid  was added,  and  loss of the differentiated  phenotype was 
scored 3-d  later.  Retinoic  acid caused some cytotoxicity under these culture 
conditions. Cytotoxicity was, however, found not to account totally for loss of 
the adipocyte phenotype.  Even if the assumption  is  made  that cytotoxicity 
affected  only differentiated cells, calculations  established  that retinoic acid 
induced  >20% of adipocytes  to lose the differentiated phenotype. 
FiGUre  2  Nonterminal  adipocyte  differentiation:  morphological 
evidence that adipocytes can undergo a proliferative response. Low 
density cells were cultured  for 8  d  in  heparinized  DME containing 
the  plasma  fraction  designated  CEPH  to  induce  nonterminal  adi- 
pocyte differentiation.  They were then  maintained  in  this  medium 
for an additional 3 d with or without (trans)  retinoic acid (RA). They 
were  subsequently  fed  30%  FCS  and  [aH]thymidine.  Cells  main- 
tained in medium containing CEPH remained differentiated and did 
not  undergo  DNA  synthesis  (A),  whereas  many  cells  treated with 
RA lost their adipocyte phenotype and incorporated  [3H]thymidine 
into  DNA  during  the  subsequent  3-d  incubation  interval  in  30% 
serum  containing  medium  (B).  Some  adipocytes,  such  as  those 
illustrated,  became labeled  before all of their intracellular triglycer- 
ide disappeared.  The results of this and  related studies established 
that  the  minimum  quantity of adipocytes  that can  lose the differ- 
entiated  phenotype and  proliferate in  such  experiments  is 26-37%; 
the maximum  number is ~70%. This range results from the fact that 
in  some cases it is difficult  to determine the difference between an 
undifferentiated cell and a differentiated cell that has been induced 
to dedifferentiate.  Arrows mark  nuclei  within  the cells.  In  (A)  the 
nuclei  are unlabeled,  whereas in  (B)  many  [3H]thymidine  labeled 
nuclei  are evident. 
Correlation  Between Morphological  and 
Enzymatic Differentiation 
Studies were also performed to establish  that the morpho- 
logical criteria for adipocyte differentiation used in this paper 
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creased activity of glycerol-3-phosphate dehydrogenase. These 
experiments were  performed  because of the  possibility that 
under certain culture conditions adipocytes might fail to ac- 
cumulate intracellular triglyceride and, therefore, appear un- 
differentiated¢ even though  they  were  differentiated by  the 
criteria of containing high levels of lipogenic enzymes (17). 
The data in table VIII show that there is an excellent correlation 
between morpholgoical and enzymatic differentiation of cells 
at various phases of coupling processes.  This further establishes 
the validity of data reported in this paper which show that the 
coupling of proadipocyte growth arrest and differentiation is a 
multistep process  that  is  primarily mediated  at  two  states, 
designated GD and GD'. 
DISCUSSION 
These results show that there are at least five biological proc- 
esses  involved in the control of proadipocyte differentiation. 
TABLE VII 
Reinitiation of Cell Proliferation of Go-Arrested Cells 
Mitogen  Labeled nuclei 
% 
Epidermal growth factor (100 ng/ml)  70 
Tumor growth factor (25%)  85 
Phorbol myristate acetate (100 ng/ml)  50 
Fetal calf serum  (10 or 30%)  90 
Methyl isobutyl xanthine (2.5-5.0 x  10  -4 M)  45 
Proadipocytes Go-arrested by  culture  at  low  density  in  heparinized  DME 
containing  25% human plasma for 4 d were treated with the listed additives 
and  [3H]thymidine  for 48 h.  The percentage of cells that  synthesize DNA 
during this interval was determined  autoradiographically.  The optimum  mi- 
togenic concentration  for each mitogen  is given parenthetically.  In all exper- 
iments the mitogens were added directly to the heparinized medium contain- 
ing human  plasma. The labeling  index for unstimulated  cells was typically 
~5%. The data are expressed as mean values of experimental  specimens (n 
> 3) minus control specimens. 
TABLE  Vlll 
Correlation between Morphological and Enzymatic Adipocyte 
Differentia tion 
Growth or differen-  Morphological 
tiated state  differentiation 
Enzymatic differentia- 
tion:* glycerol-3-phos- 
phate dehydrogenase 
activity 
% Fat cells  #mol NADH oxidized~rain~ 
mg protein X 10  2 
Rapidly growing  (3  d  in  0  0 
serum) 
Go-arrested (8 d  in BaP)  5  0 
Go-arrested (4 d  in HP)  15  10.3 +  0.5 
Differentiated  (11  d  in  75  241.2+5.3 
HP) 
Nonterminally  differen-  50  197.2 +  1.6 
tiated (8 d  in CEPH) 
Dedifferentiated  (8  d  in  5  0 
CEPH, 4 d  in RA) 
Column one lists the growth or differentiation  state of the cells that were 
assayed. The duration  of culture  and the various media that were employed 
to derive these cells are given parenthetically. 
* ]-he term "dedifferentiated" is used as an abbreviation  to designate those 
nonterminally  differentiated  cells that have been induced to lose the adi- 
pocyte phenotype. The sensitivity  of the enzyme  assay permitted detection 
of activity  greater than 400 pmol NADH oxidized/rain/rag  protein. Data are 
expressed as the mean of triplicate determinations  plus or minus  standard 
error of the mean. 
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FIGURE  3  Model  for 
the coupling of proa di- 
pocyte  growth  arrest 
and  differentiation. 
Five  phases  are  illus- 
trated:  Arrow  1), 
growth  arrest  at  a  dis- 
tinct  state  in  the  G1 
phase of the cell cycle, 
Go;  arrow  2),  nonter- 
minal  differentiation 
and arrest at Go'; arrow 
3), terminal differentia- 
tion;  arrow  4),  loss  of 
the  differentiated  phe- 
notype;  and  arrow  5), 
reinitiation  of cell  pro- 
liferation. Regulation of 
the coupling process is primarily mediated at GD and Go', because 
GD-arrested cells can either differentiate or reinitiate proliferation 
and Go'-arrested cells can either terminally differentiate or reinitiate 
proliferation typically after loss of the differentiated phenotype. 
Three processes promote differentiation and are regulated by 
physiological human plasma components. These include: (a) 
growth arrest at a distinct state in the G E  phase of the cell cycle; 
(b)  nonterminal differentiation; and (c)  terminal differentia- 
tion.  Two  processes  antagonize the  differentiation process. 
These include: (a) the reinitiation of proliferation of arrested 
cells; and (b) the dedifferentiation and proliferation of nonter- 
minally differentiated cells.  A  schematic model for the  rela- 
tionship of these stages in the control of proadipocyte prolif- 
eration and differentiation is presented in Fig. 3. 
The model illustrates that Go and Go' are states at which 
coupling of the control of cell proliferation and differentiation 
can be  mediated. Cells growth-arrested at  GD,  for example, 
have three potentialities. They can remain GD-arrested; they 
can be induced to reinitiate proliferation (Fig. 3, arrow 5); or 
they  can  be  induced to  nonterminally differentiate (Fig.  3, 
arrow  2).  Nonterminally differentiated cells at  the  GD' state 
also have three potentialities. They can remain nonterminally 
differentiated; they can dedifferentiate and/or reinitiate prolif- 
eration (Fig. 3, arrows 4 and 5); or they can terminally differ- 
entiate (Fig. 3, arrow 3). 
It is our hypothesis that the coupling of proadipocyte growth 
arrest  and  differentiation mediated  at  GD  and  Go'  mimics 
physiological growth regulation, because in vivo the control of 
stem cell proliferation is coupled to expression of a  differen- 
tiated phenotype by apparently similar mechanisms (7, 8,  11). 
For example, in hematopoietic and gastrointestinal stem cells, 
G1 growth arrest has been shown to occur before differentiation 
(8,  1  1). In vivo stages of nonterminal  and terminal differentia- 
tion have also been identified and it has been shown that the 
reinitiation of proliferation of such  nonterminally differen- 
tiated cells can be preceded by a dedifferentiation phase. These 
latter results were obtained on studies of hepatocytes (1-3). 
These  observations provide  support  for  the  physiological 
relevance for our model for the coupling of growth arrest and 
differentiation. Although the  coupling process  may  vary  in 
other cell types, we suggest that our model for the coupling of 
growth arrest and differentiation  will be more useful in explain- 
ing the  pathogenesis of human disease  states  than previous 
models for growth control (13, 18). For example, our model for 
growth control can form the basis for the hypothesis that in 
vivo and in vitro cellular aging results from acceleration in the 
terminal differentiation process,  which is regulated at GD', and that neoplastic transformation results from defective coupling 
of growth arrest and differentiation mediated at GD or GD' (14, 
20). 
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